On this page:OverviewFunded papers
ScholarIQanswers from OpenAlex

Abeona Therapeutics

FunderResearch funding and supported work

Abeona Therapeutics is a funder indexed in ScholarIQ from OpenAlex.

What is known about Abeona Therapeutics?

ScholarIQrecord summary

company in Dallas, United States

How many works does Abeona Therapeutics have?

ScholarIQindexed works

Abeona Therapeutics has 44 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for Abeona Therapeutics?

ScholarIQopenalex

The OpenAlex for Abeona Therapeutics is on the source record.

What is the ROR of Abeona Therapeutics?

ScholarIQror

The ROR for Abeona Therapeutics is on the source record.

What are the most-cited papers on Abeona Therapeutics?

ScholarIQmost cited works
Analysis of resistance mechanisms to abivertinib, a third-generation EGFR tyrosine kinase inhibitor, in patients with EGFR T790M-positive non-small cell lung cancer from a phase I trial
Yichen Zhang, Zhihong Chen, Xu‐Chao Zhang, Chong‐Rui Xu, Hong‐Hong Yan, Zhi Xie, Shaokun Chuai, Junyi Ye, Han Han‐Zhang, Zhou Zhang, Xiaoyan Bai, Jian Su, Bin Gan, Jin‐Ji Yang, Wenfeng Li, Wei Tang, Feng Luo, Xiao Xu, Yi‐Long Wu, Qing Zhou
EBioMedicine. 201946 CitationsOPEN ACCESS
470M+ articles · 14-day free trial